Forte Biosciences's market cap is currently ―. The company's EPS TTM is $-1.168; its P/E ratio is -0.63; Forte Biosciences is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	$ 25.00K
EBIT	$ -7.00M	$ -9.96M	$ -8.90M	$ -6.75M	$ -4.88M
EBITDA	$ -6.99M	$ -9.93M	$ -8.92M	$ -6.75M	$ -4.88M
Net Income Common Stockholders	$ -5.87M	$ -9.96M	$ -8.90M	$ -6.75M	$ -4.88M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 37.10M	$ 46.20M	$ 30.39M	$ 35.90M	$ 41.10M
Total Assets	$ 38.98M	$ 47.88M	$ 31.15M	$ 36.71M	$ 42.00M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -37.10M	$ -46.20M	$ -30.39M	$ -35.90M	$ -41.10M
Total Liabilities	$ 3.67M	$ 7.47M	$ 6.30M	$ 3.76M	$ 3.18M
Stockholders Equity	$ 35.31M	$ 40.41M	$ 24.88M	$ 32.95M	$ 38.86M
Cash Flow	-
Free Cash Flow	$ -9.02M	$ -9.07M	$ -5.47M	$ -5.20M	$ -2.88M
Operating Cash Flow	$ -9.00M	$ -9.00M	$ -5.47M	$ -5.20M	$ -2.88M
Investing Cash Flow	$ -16.00K	$ 10.03M	$ -9.96M	-	-
Financing Cash Flow	$ -75.00K	$ 24.78M	$ -24.00K	$ 6.00K	$ -55.00K

Currency in USD

Forte Biosciences Earnings and Revenue History

Income Statement >

Forte Biosciences Debt to Assets

Balance Sheet >

Forte Biosciences Cash Flow

Cash Flow >

Forte Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing